February 28, 2017
(Scientific American) – India, one of the world’s biggest consumers of antibiotics, has issued new national guidelines on their use as part of a drive to fight the rise of drug-resistant superbugs. Superbugs are seen as a growing threat to modern medicine, with the emergence in the past year of infections resistant to even last-resort antibiotics. In India, antibiotic-resistant neonatal infections claim the lives of 60,000 newborn babies each year, according to the Review on Antimicrobial Resistance paper published in 2016.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.